Is Agios Pharmaceuticals, Inc. (AGIO) a Buy, Sell, or Hold?
NASDAQ : AGIO
Agios Pharmaceuticals, Inc. — Analyst Ratings
$35.99 USD
-$0.98 (-2.65%)
- Volume
- 802.34K
- Average Volume
- 1.08M
- Market Capitalization
- $2.14B
- P/E Ratio
- -4.96
- Dividend Yield
- 0.00%
- Price Target
- $41.00
- Year High
- $46.00
- Year Low
- $22.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.19
Analyst Consensus Summary
Consensus Rating
Sell
29 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-12.2%
vs Current Price
Price Target
$41.00
Average TargetPrice Target Range
Lowest Target
$32.00
12.5% UPSIDE
Average Target
$41.00
Median Estimate
Highest Target
$52.00
-30.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 29
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 22 | 7 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Emily Bodnar | $52 | $37.77 | 2026-07-21 11:00 AM | 37.7% |
| H.C. Wainwright | Emily Bodnar | $54 | $29.46 | 2026-06-15 06:49 AM | 83.3% |
| H.C. Wainwright | Emily Bodnar | $50 | $26.9312 | 2026-04-20 12:07 PM | 85.7% |
| Truist Financial | Greg Renza | $39 | $28.415 | 2026-02-12 11:40 AM | 37.3% |
| Truist Financial | Gregory Renza | $38 | $29.17 | 2025-12-24 11:55 AM | 30.3% |